Clinical trial
90-day Postoperative Morbidity and Mortality After Elective Surgery for Gastric Cancer
NCT06277908 is registered in ClinicalTrials.gov with P. Herzen Moscow Oncology Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 90-day Postoperative Morbidity and Mortality After Elective Surgery for Gastric Cancer
- Lead sponsor
- P. Herzen Moscow Oncology Research Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 18, 2024
- Completion date
- December 31, 2024
- Enrollment
- 700 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer, siewert type iii adenocarcinoma of esophagogastric junction, stomach cancer